Food and Drug Administration's regulatory shift on direct-to-consumer genetic tests for cancer risk. - PubMed - NCBI

Food and Drug Administration's regulatory shift on direct-to-consumer genetic tests for cancer risk. - PubMed - NCBI

Cancer. 2018 Nov 2. doi: 10.1002/cncr.31773. [Epub ahead of print]

Food and Drug Administration's regulatory shift on direct-to-consumer genetic tests for cancer risk.

Yang YT1,2,3, Zettler PJ4.

Author information

PMID:

 

30387874

 

DOI:

 

10.1002/cncr.31773